Ultragenyx Pharmaceutical Inc 10-Q for FY2025 Q3
Ultragenyx Pharmaceutical Inc. (RARE)
10-Q
2025-11-05
For: 2025-09-30
View Original
Added on
April 09, 2026
About this 10-Q
Ultragenyx Pharmaceutical Inc filed this 10-Q on November 5, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $159.93M
- up 14.7% from $139.49M a year earlier
- Net loss
- $180.41M
- compared with a net loss of $133.52M a year earlier
- Diluted EPS
- -$1.81
- compared with -$1.40 a year earlier